Published in J Neuroimmunol on November 03, 2016
Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study. J Neurovirol (2017) 0.75
Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults. Fluids Barriers CNS (2017) 0.75
Microglia: a sensor for pathological events in the CNS. Trends Neurosci (1996) 12.00
Structure and function of the blood-brain barrier. Neurobiol Dis (2009) 7.64
The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis (2004) 5.49
Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci (2001) 3.11
Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med (1992) 2.48
Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis (2012) 2.37
Immunologically privileged sites. Adv Immunol (1977) 2.35
Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther (2010) 1.99
Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta (2001) 1.99
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry (1994) 1.98
Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis (1997) 1.90
The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev (1997) 1.73
HIV tat and neurotoxicity. Microbes Infect (2006) 1.69
Early penetration of the blood-brain-barrier by HIV. Neurology (1988) 1.62
Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci (2003) 1.61
Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol (1992) 1.61
Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis (2011) 1.59
Cerebrospinal fluid neopterin is brain-derived and not associated with blood-CSF barrier dysfunction in non-inflammatory affective and schizophrenic spectrum disorders. J Psychiatr Res (2013) 1.50
Barriers in the brain: a renaissance? Trends Neurosci (2008) 1.49
Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr Neuropharmacol (2008) 1.38
External quality assessment in clinical neurochemistry: survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/serum quotients. Clin Chem (1995) 1.32
Elevated IP10 levels are associated with immune activation and low CD4⁺ T-cell counts in HIV controller patients. AIDS (2014) 1.28
Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol (1988) 1.21
Pathobiology of human immunodeficiency virus dementia. Semin Neurol (1999) 1.17
Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China. J Neurovirol (2013) 1.10
Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J Virol (2007) 1.07
Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil. J Neurovirol (2013) 1.05
The blood-brain barrier in neuroimmunology: Tales of separation and assimilation. Brain Behav Immun (2014) 1.03
Biomarkers of HIV related central nervous system disease. Int Rev Psychiatry (2008) 1.02
Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection. J Neuroimmune Pharmacol (2013) 0.98
Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Scand J Infect Dis (1994) 0.95
Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals--correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels. J Neurovirol (2001) 0.92
Establishment of a human in vitro model of the outer blood-retinal barrier. J Anat (2007) 0.89
Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex. Handb Clin Neurol (2007) 0.87
T-Cell Signaling in HIV-1 Infection. Open Virol J (2013) 0.83
Elevated Biomarkers of Inflammation and Coagulation in Patients with HIV Are Associated with Higher Framingham and VACS Risk Index Scores. PLoS One (2015) 0.83
Mannan-binding lectin in cerebrospinal fluid: a leptomeningeal protein. Fluids Barriers CNS (2012) 0.82
HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients. AIDS Res Hum Retroviruses (2015) 0.81
Prevalence and predictors of blood-brain barrier damage in the HAART era. J Neurovirol (2014) 0.79
Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B. J Neurovirol (2016) 0.78
Trans-blood-brain-barrier albumin leakage and comparisons of intrathecal IgG synthesis calculations in multiple sclerosis patients. Multiple Sclerosis Study Group, Alpha Interferon Study Group, and Azathioprine Study Group. J Neuroimmunol (1993) 0.77
Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med (2011) 1.42
Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B. J Neurovirol (2016) 0.78
Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study. J Neurovirol (2017) 0.75